The African American Heart Failure Trial: A Clinical Trial Update
- 1 October 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (7) , 44-48
- https://doi.org/10.1016/j.amjcard.2005.07.033
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial InfarctionCirculation Research, 2004
- Introduction*1Journal of Cardiac Failure, 2003
- Oxidative Stress and Endothelial Dysfunction in Heart FailureCongestive Heart Failure, 2002
- Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in MiceCirculation, 2001
- Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular DysfunctionNew England Journal of Medicine, 2001
- HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approachesJournal of Cardiac Failure, 1999
- Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trialsJournal of Cardiac Failure, 1999
- Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.Journal of the American College of Cardiology, 1998
- Endothelial function in chronic congestive heart failureThe American Journal of Cardiology, 1992
- Oxygen free radicals and congestive heart failure.Heart, 1991